Related references
Note: Only part of the references are listed.Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease
Kai Nowak et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
H. Quach et al.
LEUKEMIA (2010)
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
J. P. Laubach et al.
LEUKEMIA (2009)
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer
Rakhi P. Naik et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors
Jamie Case et al.
EXPERIMENTAL HEMATOLOGY (2007)
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation
Endri Mauro et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
Mervin C. Yoder et al.
BLOOD (2007)
A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood
Dan G. Duda et al.
NATURE PROTOCOLS (2007)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Proteasome inhibition in multiple myeloma
Martin Kropff et al.
EUROPEAN JOURNAL OF CANCER (2006)
Prognostic value of bone marrow angiogenesis in multiple myeloma: Use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters
Sahibinder Singh Bhatti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating endothelial progenitor cells in multiple myeloma:: implications and significance
H Zhang et al.
BLOOD (2005)
Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients
LV Beerepoot et al.
ANNALS OF ONCOLOGY (2004)
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
P Mancuso et al.
BLOOD (2001)